Mechanistic Study of Drying Phenomena of Highly Concentrated Protein Therapeutics—Drying Kinetics and Protein Aggregation

References

1. 1.↵
   1. Dimitrov D. S.

   Therapeutic Proteins. Methods Mol. Biol. 2012, 899, 1–26.

   OpenUrlCrossRefPubMed
2. 2.↵
   Research and Markets: Therapeutic Proteins Global Market Report 2020. https://www.researchandmarkets.com/reports/4871552/therapeutic-proteins-global-market-report-2020?utm_source=dynamic&utm_medium=BW&utm_code=d2ltg5&utm_campaign=1330661+-+Global+Therapeutic+Proteins+Market+Report+2020%3a+Market+was+Valued+at+%2493.14+Billion+in+2018+and+is+Expected+to+Grow+to+%24172.87+Billion+through+2022&utm_exec=chdo54bwd (accessed Sept 16, 2020).
3. 3.↵
   1. Shire S. J.

   Formulation and Manufacturability of Biologics. Curr. Opin. Biotech. 2009, 20 (6), 708–714.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Jezek J.,
   2. Darton N. J.,
   3. Derham B. K.,
   4. Royle N.,
   5. Simpson I.

   Biopharmaceutical Formulations for Pre-Filled Delivery Devices. Expert Opin. Drug Delivery 2013, 10 (6), 811–828.

   OpenUrl
5. 5.↵
   1. Sacha G.,
   2. Rogers J. A.,
   3. Miller R. L.

   Pre-Filled Syringes: A Review of the History, Manufacturing and Challenges. Pharm. Dev. Technol. 2015, 20 (1), 1–11.

   OpenUrl
6. 6.↵
   1. Shire S. J.,
   2. Shahrokh Z.,
   3. Liu J.

   Challenges in the Development of High Protein Concentration Formulations. J. Pharm. Sci. 2004, 93 (6), 1390–1402.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Pindrus M.,
   2. Shire S. J.,
   3. Kelley R. F.,
   4. Demeule B.,
   5. Wong R.,
   6. Xu Y. R.,
   7. Yadav S.

   Solubility Challenges in High Concentration Monoclonal Antibody Formulations: Relationship with Amino Acid Sequence and Intermolecular Interactions. Mol. Pharmaceutics 2015, 12 (11), 3896–3907.

   OpenUrl
8. 8.↵
   1. Badkar A.,
   2. Wolf A.,
   3. Bohack L.,
   4. Kolhe P.

   Development of Biotechnology Products in Pre-Filled Syringes: Technical Considerations and Approaches. AAPS PharmSciTech 2011, 12 (2), 564–572.

   OpenUrlPubMed
9. 9.↵
   1. Vaughan T.,
   2. Osbourn J.,
   3. Jallal B.

   1. Mahler H. C.,
   2. Allmendinger A.

   Stability, Formulation, and Delivery of Biopharmaceuticals. In Methods and Principles in Medicinal Chemistry; Vaughan T., Osbourn J., Jallal B., Eds.; Wiley‐VCH: Weinheim, Germany, 2017; Chapter 14, pp 469–491.
10. 10.↵
    1. Lowe D.,
    2. Dudgeon K.,
    3. Rouet R.,
    4. Schofield P.,
    5. Jermutus L.,
    6. Christ D.

    Aggregation, Stability, and Formulation of Human Antibody Therapeutics. Adv. Protein Chem. Struct. Biol. 2011, 84, 41–61.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Overcashier D. E.,
    2. Chan E. K.,
    3. Hsu C. C.

    Technical Considerations in the Development of Prefilled Syringes for Protein Products. Am. Pharm. Rev. 2006, 9, 77–83.

    OpenUrl
12. 12.↵
    1. Jameel F.,
    2. Skoug J. W.,
    3. Nesbitt R. R.

    1. Shieu W.,
    2. Maa Y. F.

    Considerations and Challenges When Filling High-Concentration Monoclonal Antibody Formulations into Prefilled Syringes. In Development of Biopharmaceutical Drug-Device Products; Jameel F., Skoug J. W., Nesbitt R. R., Eds.; AAPS Advances in the Pharmaceutical Sciences Vol. 35; Springer, 2020; Chapter 24, pp 591–612.
13. 13.↵
    1. Shieu W.,
    2. Torhan S. A.,
    3. Chan E.,
    4. Hubbard A.,
    5. Gikanga B.,
    6. Stauch O. B.,
    7. Maa Y. F.

    Filling of High-Concentration Monoclonal Antibody Formulations into Pre-Filled Syringes: Filling Parameter Investigation and Optimization. PDA J. Pharm. Sci. Technol. 2014, 68 (2), 153–163.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Dreckmann T.,
    2. Boeuf J.,
    3. Ludwig I. S.,
    4. Lumkemann J.,
    5. Huwyler J.

    Low Volume Aseptic Filling: Impact of Pump Systems on Shear Stress. Eur. J. Pharm. Biopharm. 2020, 147, 10–18.

    OpenUrl
15. 15.↵
    1. Shieu W.,
    2. Lamar D.,
    3. Stauch O. B.,
    4. Maa Y. F.

    Filling of High-Concentration Monoclonal Antibody Formulations: Investigating Underlying Mechanisms That Affect Precision of Low-Volume Fill by Peristaltic Pump. PDA J. Pharm. Sci. Technol. 2016, 70 (2), 143–156.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Shieu W.,
    2. Stauch O. B.,
    3. Maa Y. F.

    Filling of High-Concentration Monoclonal Antibody Formulations into Pre-Filled Syringes: Investigating Formulation-Nozzle Interactions to Minimize Nozzle Clogging. PDA J. Pharm. Sci. Technol. 2015, 69 (3), 417–426.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Hanslip S.,
    2. Desai K. G.,
    3. Palmer M.,
    4. Bell S.,
    5. Schofield P.,
    6. Varma P.,
    7. Roche F.,
    8. Colandene J. D.,
    9. Smith T. M.,
    10. Nesta D. P.

    Syringe Filling of High-Concentration mAb Formulation: Slow Suck-Back Pump Speed Prevented Filling Needle Clogging. J. Pharm. Sci. 2017, 106 (12), 3651–3653.

    OpenUrl
18. 18.↵
    1. Harris R. J.,
    2. Kabakoff B.,
    3. Macchi F. D.,
    4. Shen F. J.,
    5. Kwong M.,
    6. Andya J. D.,
    7. Shire S. J.,
    8. Bjork N.,
    9. Totpal K.,
    10. Chen A. B.

    Identification of Multiple Sources of Charge Heterogeneity in a Recombinant Antibody. J. Chromatogr. B: Biomed. Sci. Appl. 2001, 752 (2), 233–245.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Dubitzky W.,
    2. Wolkenhauer O.,
    3. Cho K. H.,
    4. Yokota H.

    1. Somvanshi P. R.,
    2. Venkatesh K. V.

    Hill equation. In Encyclopedia of Systems Biology; Dubitzky W., Wolkenhauer O., Cho K. H., Yokota H., Eds.; Springer: New York, 2013; pp 892–895.
20. 20.↵
    1. Markossian S.,
    2. Sittampalam G. S.,
    3. Grossman A.

    1. Auld D. S.,
    2. Inglese J.,
    3. Dahlin J. L.

    ; Assay Interference by Aggregation. In Assay Guidance Manual; Markossian S., Sittampalam G. S., Grossman A. Eds.; Eli Lilly & Company and the National Center for Advancing Translational Sciences: Bethesda, MD, 2004.
21. 21.↵
    1. Fallarero A.,
    2. Hanski L.,
    3. Vuorela P.

    How to Translate a Bioassay into a Screening Assay for Natural Products: General Considerations and Implementation of Antimicrobial Screens. Planta Med. 2014, 80 (14), 1182–1199.

    OpenUrl
22. 22.↵
    1. Warne N.,
    2. Mahler H. C.

    1. Singh S. K.

    Sucrose and Trehalose in Therapeutic Protein Formulations. In Challenges in Protein Product Development; Warne N., Mahler H. C., Eds.; AAPS Advances in the Pharmaceutical Sciences Series Vol. 38; Springer, 2018. pp 63–95.
23. 23.↵
    1. Dreckmann T.,
    2. Ludwig I. S.,
    3. Luemkemann J.,
    4. Huwyler J.

    Low-Volume Aseptic Filling Using a Linear Peristaltic Pump, PDA J. Pharm. Sci. Technol. 2021, 75 (3), 245–257.

    OpenUrlAbstract/FREE Full Text